Research Archive — Page 57 of 194
-
October 3, 2019
Team discovers one more piece to the autism puzzle
Vanderbilt investigators have linked genetic mutations in a single receptor to epilepsy, autism and intellectual disability. -
October 3, 2019
A step toward gastric cancer
New research findings provide insight into the detrimental events that develop in response to H. pylori infection. -
October 3, 2019
A catalog of DNA replication proteins
Vanderbilt scientists have identified 593 proteins that are enriched at sites of DNA duplication and chromatin packaging of newly synthesized DNA. -
October 3, 2019
Diabetes drug study explores cardiovascular risks for patients with kidney disease
An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease. -
October 2, 2019
Research team sorts out drug screen false positive results
Vanderbilt investigators have identified 13 previously unknown drug compounds that cause false positive screenings for amphetamines, buprenorphine (an opioid), cannabinoids and methadone. -
October 1, 2019
Pua lands NIH Director’s New Innovator Award
Heather Pua, MD, PhD, one of 60 investigators to receive the 2019 NIH Director’s New Innovator Award, will explore a novel type of cell signaling by RNAs in allergic airway inflammation. -
September 25, 2019
Study shines light on architecture of kidney disease
A study of 280,000 U.S. veterans, including 56,000 African Americans, has identified in greater detail than ever before the genetic architecture of kidney function and chronic kidney disease (CKD), according to researchers at Vanderbilt University Medical Center and their colleagues.